ABBOTT LABORATORIES (ABT)       110.97  -0.82 (-0.73%)

110.97  -0.82 (-0.73%)

US0028241000 - Common Stock

ABBOTT LABORATORIES110.97

NYSE:ABT (2/6/2023, 12:31:54 PM)-0.82 (-0.73%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Health Care Equipment & Supplies

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 01-25 2023-01-25/bmo Earnings (Next) 04-18 2023-04-18/amc
Ins Owners 0.51% Inst Owners 73.13%
Market Cap 193.48B Shares 1.74B
PE 20.78 Fwd PE 24.94
Dividend Yield 1.81% Analysts 79.31
IPO 03-01 1937-03-01

Stock Screener Links

Screen Image

New York Stock Exchange, Inc. Stock Screener

Find more stocks on New York Stock Exchange, Inc.

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ABT Daily chart

Company Profile

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company is headquartered in Abbott Park, Illinois. The firm operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Company Info

ABBOTT LABORATORIES

100 Abbott Park Rd

ABBOTT PARK ILLINOIS 60064

P: 12246676100.0

CEO: Robert B. Ford

Employees: 113000

Website: https://www.abbott.com/

ABT News

News Image2 days ago - The Motley Fool2 Beaten-Down Stocks With Stable Dividends to Buy In 2023

You can bet the farm on these companies' dividends.

News Image2 days ago - The Motley Fool3 Unstoppable Dividend Stocks to Buy in February

All three belong to the elite group of stocks known as Dividend Kings.

News Image3 days ago - ChartmillNYSE:ABT may be ready to breakout.News Image4 days ago - Seeking AlphaAbbott receives FDA, EMA authorizations for cardiac catheters (NYSE:ABT)

Abbott Laboratories (ABT) has launched its TactiFlex ablation catheter (sensor enabled) in Europe after receiving CE Mark.The company said that TactiFlex can reduce procedure...

News Image5 days ago - The Motley Fool2 Top Dividend Growth Stocks to Buy in February

They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.

News Image6 days ago - Seeking AlphaFDA to overhaul food safety division in wake of baby formula issues (NYSE:ABT)

The US FDA will reorganize its food safety division to consolidate several functions in the aftermath of 2022's baby formula shortage to prevent a similar occurrence.

ABT Twits

Here you can normally see the latest stock twits on ABT, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example